Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009
by National Heart, Lung, and Blood Institute (NHLBI).
Recruitment status was Recruiting
Study NCT00799435 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received on November 26, 2008. Last Updated on July 29, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Heart Failure, Diastolic
Additional conditions recognized in this trial
Diabetes Mellitus
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Heart Diseases
Metabolic Diseases
Interventions listed in this trial
Exenatide
Additional drug interventions recognized in this trial
Glucagon-Like Peptide 1
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Hypoglycemic Agents
Incretins
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content